We use cookies to help provide you with the best possible online experience. Please read our Privacy Policy for information about which cookies we use and what information we collect on our site. By continuing to use this site, you agree that we may store and access cookies on your device.
WuXi Biologics (2269.HK) announced that the company has been selected by Hang Seng Indexes as a constituent of the Hang Seng HK 35 Index (“HSHK35”) effective 10 September, 2018.